Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3050880

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    28.9.2014
  • EP published:
    19.6.2019
  • EP application number:
    14849754.8
  • Max expiry date:
    27.9.2034
  • Title:
    QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER

Timeline

Today
28.9.2014EP application
19.6.2019EP Publication

Owner

  • Name:
    Chia Tai Tianqing Pharmaceutical Group Co.,Ltd
  • Address:
    No. 369 Yuzhou South Road Haizhou District, 222062, Lianyungang, Jiangsu, CN
  • Name:
    Centaurus BioPharma Co., Ltd.
  • Address:
    No.16 Building No.3 Minzhuang Road Haidian District, 100195, Beijing, CN
  • Name:
    Lianyungang Runzhong Pharmaceutical Co., Ltd.
  • Address:
    No. 16 Jinqiao Road Dapu Industry Park Lianyungang Economy and Technology Development Zone, 222069, Lianyungang, Jiangsu, CN

Inventor

  • Name:
    XIAO, Dengming
  • Address:
    Beijing, CN
  • Name:
    ZHU, Yan
  • Address:
    Beijing, CN
  • Name:
    HU, Yuandong
  • Address:
    Beijing, CN
  • Name:
    WANG, Huting
  • Address:
    Beijing, CN
  • Name:
    LI, Jijun
  • Address:
    Beijing, CN
  • Name:
    PENG, Yong
  • Address:
    Beijing, CN
  • Name:
    ZHANG, Hui
  • Address:
    Beijing, CN
  • Name:
    LUO, Hong
  • Address:
    Beijing, CN
  • Name:
    KONG, Fansheng
  • Address:
    Beijing, CN
  • Name:
    HAN, Yongxin
  • Address:
    Beijing, CN

Priority

  • Number:
    201310452885
  • Date:
    28.9.2013
  • Country:
    CN

Classification

  • Categories:
    C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/14, A61K 31/517, A61K 31/5377, A61P 35/00

Upload documents